microsatellite stable colorectal cancer
Showing 1 - 7 of 7
Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States
Terminated
- Pancreatic Adenocarcinoma
- +13 more
- GB1275
- +2 more
-
San Francisco, California
- +7 more
Aug 17, 2022
Any Advanced Solid Tumors, Triple Negative Breast Cancer, Non Small Cell Lung Cancer Trial in United States (NT-I7,
Recruiting
- Any Advanced Solid Tumors
- +6 more
-
Tampa, Florida
- +7 more
Jul 13, 2022
Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer Trial in Worldwide
Recruiting
- Cervical Cancer
- +4 more
-
La Jolla, California
- +19 more
Jun 28, 2022
Microsatellite Stable Colorectal Cancer Trial in United States (grapiprant, grapiprant and pembrolizumab)
Active, not recruiting
- Microsatellite Stable Colorectal Cancer
- grapiprant
- grapiprant and pembrolizumab
-
Phoenix, Arizona
- +3 more
Apr 21, 2022
Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,
Recruiting
- Solid Tumor
- +8 more
- TBio-6517
- Pembrolizumab
-
Phoenix, Arizona
- +10 more
Feb 21, 2022
Microsatellite Unstable Colorectal Cancer, Microsatellite Stable Colorectal Cancer, Mismatch Repair Proficient Colorectal Cancer
Active, not recruiting
- Microsatellite Unstable Colorectal Cancer
- +3 more
- Ipilimumab
- +4 more
-
Gilbert, Arizona
- +31 more
Dec 21, 2021
Microsatellite Stable Colorectal Cancer, Pancreatic Cancer, MSI High Colorectal Cancer Trial in Boston (Nivolumab, Ipilimumab,
Recruiting
- Microsatellite Stable Colorectal Cancer
- +2 more
- Nivolumab
- +2 more
-
Boston, MassachusettsMassachusetts general Hospital
Mar 24, 2021